Molecular Pharmacology: 102 (1)

July 01, 2022; Volume 102,Issue 1

Articles

You have access
Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development
Carlos E. Sanz-Rodríguez, Benjamin Hoffman, Paul J. Guyett, Andrei Purmal, Baljinder Singh, Michael P. Pollastri and Kojo Mensa-Wilmot

Molecular Pharmacology July 2022, 102 (1) 1-16; DOI: https://doi.org/10.1124/molpharm.121.000430
You have access
Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia
Sharan R. Srinivasan, Haoran Huang, Wei-Chih Chang, Joshua A. Nasburg, Hai M. Nguyen, Tim Strassmaier, Heike Wulff and Vikram G. Shakkottai

Molecular Pharmacology July 2022, 102 (1) 17-28; DOI: https://doi.org/10.1124/molpharm.121.000478
You have access
GPR83 Engages Endogenous Peptides from Two Distinct Precursors to Elicit Differential Signaling
Seshat M. Mack, Ivone Gomes, Amanda K. Fakira, Mariana Lemos Duarte, Achla Gupta, Lloyd Fricker and Lakshmi A. Devi

Molecular Pharmacology July 2022, 102 (1) 29-38; DOI: https://doi.org/10.1124/molpharm.122.000487

Open Access
The Heartwarming Effect of Brown Adipose Tissue
Kelsey M. Pinckard and Kristin I. Stanford

Molecular Pharmacology July 2022, 102 (1) 39-50; DOI: https://doi.org/10.1124/molpharm.121.000328
You have access
Calcium Cycling as a Mediator of Thermogenic Metabolism in Adipose Tissue
Adrienne R. Guarnieri, Tyler W. Benson and Michael Tranter

Molecular Pharmacology July 2022, 102 (1) 51-59; DOI: https://doi.org/10.1124/molpharm.121.000465
You have access
Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose Inflammation
Haneen S. Dwaib, Ibrahim AlZaim, Ghina Ajouz, Ali H. Eid and Ahmed El-Yazbi

Molecular Pharmacology July 2022, 102 (1) 60-79; DOI: https://doi.org/10.1124/molpharm.121.000338